Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas
- PMID: 27605878
- PMCID: PMC4968124
- DOI: 10.3748/wjg.v22.i28.6424
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas
Abstract
Pancreatic ductal adenocarcinoma carries a poor prognosis with annual deaths almost matching the reported incidence rates. Surgical resection offers the only potential cure. Yet, even among patients that undergo tumor resection, recurrence rates are high and long-term survival is scarce. Various tumor-related factors have been identified as predictors of survival after potentially curative resection. These factors include tumor size, lymph node disease, tumor grade, vascular invasion, perineural invasion and surgical resection margin. This article will re-evaluate the importance of these factors based on recent publications on the topic, with potential implications for treatment and outcome in patients with pancreatic cancer.
Keywords: Pancreatic cancer; Prognostic factors; Survival.
Similar articles
-
Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future.Dig Liver Dis. 2018 Oct;50(10):979-990. doi: 10.1016/j.dld.2018.08.009. Epub 2018 Aug 20. Dig Liver Dis. 2018. PMID: 30205952 Review.
-
Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.Cancer. 2009 Sep 15;115(18):4080-9. doi: 10.1002/cncr.24503. Cancer. 2009. PMID: 19626671
-
Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.J Surg Oncol. 2015 Sep;112(4):396-402. doi: 10.1002/jso.24011. Epub 2015 Aug 25. J Surg Oncol. 2015. PMID: 26303811 Clinical Trial.
-
Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?Eur J Surg Oncol. 2014 Nov;40(11):1578-85. doi: 10.1016/j.ejso.2014.04.012. Epub 2014 May 21. Eur J Surg Oncol. 2014. PMID: 24923739
-
Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.J Hepatobiliary Pancreat Sci. 2016 Sep;23(9):523-32. doi: 10.1002/jhbp.374. Epub 2016 Aug 15. J Hepatobiliary Pancreat Sci. 2016. PMID: 27524388 Review.
Cited by
-
A Preoperative Prognostic Scoring System to Predict Prognosis for Resectable Pancreatic Cancer: Who Will Benefit from Upfront Surgery?J Gastrointest Surg. 2019 May;23(5):990-996. doi: 10.1007/s11605-018-3972-x. Epub 2018 Sep 21. J Gastrointest Surg. 2019. PMID: 30242645
-
Comparison of Radical Antegrade Modular Pancreatosplenectomy with Standard Retrograde Pancreatosplenectomy for Left-Sided Pancreatic Cancer: A Meta-Analysis and Experience of a Single Center.Med Sci Monit. 2019 Jun 21;25:4590-4601. doi: 10.12659/MSM.914540. Med Sci Monit. 2019. PMID: 31221951 Free PMC article.
-
The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection.Ann Surg Oncol. 2020 Jun;27(6):2017-2024. doi: 10.1245/s10434-019-08161-6. Epub 2020 Jan 3. Ann Surg Oncol. 2020. PMID: 31900809 Free PMC article.
-
Natural History and Treatment Trends in Pancreatic Cancer Subtypes.J Gastrointest Surg. 2019 Apr;23(4):768-778. doi: 10.1007/s11605-019-04113-3. Epub 2019 Jan 31. J Gastrointest Surg. 2019. PMID: 30706376
-
Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.PLoS One. 2019 May 6;14(5):e0215915. doi: 10.1371/journal.pone.0215915. eCollection 2019. PLoS One. 2019. PMID: 31059520 Free PMC article.
References
-
- Kos FT, Yazici O, Civelek B, Seker M, Arik Z, Aksoy S, Uncu D, Ozdemir N, Zengin N. Evaluation of the effect of comorbidity on survival in pancreatic cancer by using “Charlson Comorbidity Index” and “Cumulative Illness Rating Scale”. Wien Klin Wochenschr. 2014;126:36–41. - PubMed
-
- Akhtar-Danesh GG, Finley C, Akhtar-Danesh N. Long-term trends in the incidence and relative survival of pancreatic cancer in Canada: A population-based study. Pancreatology. 2016;16:259–265. - PubMed
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical